Finance

Lists
Why is 300255 down 2,02%?
Dive Deeper
300255:SHE
Hebei Changshan Biochemical Pharm Co Ltd
19,88 CNY
-2,02%
(-0,41) 1D
16 ოქტ, 15:04:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300255...
Open
20,65 CNY
High
21,15 CNY
Low
19,75 CNY
Mkt. cap
19,35 მლრდ.
Avg. vol.
17,59 მლნ.
Volume
21,03 მლნ.
52-wk high
71,71 CNY
52-wk low
19,75 CNY
EPS
-0,38 CNY
Shares outstanding
919,06 მლნ.
No. of employees
1 ათ.
Open
20,65 CNY
High
21,15 CNY
Low
19,75 CNY
Mkt. cap
19,35 მლრდ.
Avg. vol.
17,59 მლნ.
Volume
21,03 მლნ.
52-wk high
71,71 CNY
52-wk low
19,75 CNY
EPS
-0,38 CNY
Shares outstanding
919,06 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
巴士的報
巴士的報
·
17 წუთის წინ
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
47 წუთის წინ
Traders work on the floor of the NYSE in New York
The National Law Review
The National Law Review
·
19 წუთის წინ
Kaplan Fox Continues to Remind Honeywell Aerospace Inc. (NASDAQ
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar on November 4 to Present Q2 Financial Results
About Hebei Changshan Biochemical Pharm Co Ltd
CEO-
Employees1,19 ათ.
Founded1992
Headquarters-
SectorPharmaceutical industry
Websitehbcsbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
189,61 მლნ.
193,91 მლნ.
256,10 მლნ.
219,72 მლნ.
Cost of goods sold
164,51 მლნ.
281,46 მლნ.
193,11 მლნ.
179,86 მლნ.
Cost of revenue
164,51 მლნ.
281,46 მლნ.
193,11 მლნ.
179,86 მლნ.
Research and development expenses
8,72 მლნ.
9,51 მლნ.
7,23 მლნ.
8,69 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,72 მლნ.
91,72 მლნ.
30,76 მლნ.
30,39 მლნ.
Operating expense
33,60 მლნ.
143,40 მლნ.
38,30 მლნ.
42,40 მლნ.
Total operating expenses
198,11 მლნ.
424,86 მლნ.
231,40 მლნ.
222,26 მლნ.
Operating income
-8,50 მლნ.
-230,95 მლნ.
24,70 მლნ.
-2,54 მლნ.
Other non operating income
-1,50 მლნ.
-28,67 მლნ.
-3,36 მლნ.
3,51 მლნ.
EBT including unusual items
-21,20 მლნ.
-301,55 მლნ.
5,20 მლნ.
-24,37 მლნ.
EBT excluding unusual items
-34,61 მლნ.
-282,26 მლნ.
-355,86 ათ.
-25,59 მლნ.
Income tax expense
-435,25 ათ.
8,93 მლნ.
1,82 მლნ.
761,85 ათ.
Effective tax rate
2,05%
-2,96%
35,03%
-3,13%
Other operating expenses
-723,45 ათ.
5,43 მლნ.
2,02 მლნ.
759,88 ათ.
Net income
-15,73 მლნ.
-313,08 მლნ.
5,87 მლნ.
-22,63 მლნ.
Net profit margin
-8,29%
-161,45%
2,29%
-10,30%
Earnings per share
-
-
-
-
Interest and investment income
2,00 მლნ.
531,86 ათ.
117,28 ათ.
28,28 ათ.
Interest expense
-19,57 მლნ.
-28,42 მლნ.
-21,82 მლნ.
-23,56 მლნ.
Net interest expenses
-17,56 მლნ.
-27,89 მლნ.
-21,70 მლნ.
-23,53 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
9,49 მლნ.
-214,14 მლნ.
41,52 მლნ.
14,11 მლნ.
Gain or loss from assets sale
17,64 ათ.
228,40 ათ.
-
6,30 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები